#AAO22 conference in Chicago (Photo credit: Associate editor Kyle LaHucik)

#AAO22: In bid for first FDA nod in ge­o­graph­ic at­ro­phy, Apel­lis claims an­oth­er first in eye dis­ease field

CHICA­GO — Eight weeks be­fore pa­tients and in­dus­try find out if the FDA ap­proves the first treat­ment for ge­o­graph­ic at­ro­phy, an ad­vanced form of age …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.